{"slideshow_credits": null, "snippet": "Abbott Laboratories said it reached an agreement with the federal government and most states to pay $1.6 billion in connection with its marketing of the anti-seizure drug Depakote.", "abstract": "Abbott Laboratories says it reached an agreement with the federal government and most states to pay $1.6 billion in connection with its illegal marketing of the anti-seizure drug Depakote.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"lastname": "SCHMIDT", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "S."}, {"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 2, "organization": ""}], "original": "By MICHAEL S. SCHMIDT and KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/05/08/business/abbott-to-pay-1-6-billion-over-illegal-marketing.html", "lead_paragraph": "Abbott Laboratories said it reached an agreement with the federal government and most states to pay $1.6 billion in connection with its marketing of the anti-seizure drug Depakote.", "headline": {"seo": "Abbott to Pay $1.6 Billion Over Illegal Marketing", "main": "Abbott Settles Marketing Lawsuit", "print_headline": "Abbott Settles Marketing Lawsuit"}, "_id": "53f67fa138f0d821a37b22a8", "word_count": "662", "multimedia": [], "pub_date": "2012-05-08T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Abbott Laboratories", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Suits and Litigation", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "Seizures (Medical)", "name": "subject", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}